InVivo Therapeutics Holdings Corp. (NVIV) SEC filings

NVIV SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NVIV overview →

9 measured NVIV SEC filing events.

DateHeadlineEvent5-minTo close
Form 8-K INVIVO THERAPEUTICS HOLD For: Feb 02SEC filing · Form 8-K+48.16%+42.16%
Form 8-K INVIVO THERAPEUTICS HOLD For: Feb 01SEC filing · Form 8-K+3.85%+27.31%
Form 8-K INVIVO THERAPEUTICS HOLD For: Dec 29SEC filing · Form 8-K—+4.32%
Form ARS INVIVO THERAPEUTICS HOLD For: Dec 31SEC filing · Form ARS+14.84%+39.05%
Form DEF 14A INVIVO THERAPEUTICS HOLD For: Dec 29SEC filing · Form DEF+14.84%+39.05%
Form 8-K INVIVO THERAPEUTICS HOLD For: Dec 01SEC filing · Form 8-K-0.68%-3.40%
Form 8-K INVIVO THERAPEUTICS HOLD For: Nov 30SEC filing · Form 8-K+0.00%-5.02%
Form 8-K INVIVO THERAPEUTICS HOLD For: Nov 21SEC filing · Form 8-K—+2.65%
Form 10-Q INVIVO THERAPEUTICS HOLD For: Sep 30SEC filing · Form 10-Q+0.00%-2.78%
Get an email when NVIV moves on news →
Keep exploring

More NVIV: earnings → · analyst actions → · NVIV overview →

Other Healthcare names and their SEC filings

TickerEventsMedian 30-min% positive
ENZOLYTICS INC (ENZC)14+0.73%50%
GENFIT ORD (GNFTF)140.00%0%
CohBar, Inc. (CWBR)13+0.67%73%
STELLAR BIOTECHNOLOGIES (SBOT)13-9.00%0%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.